Authors
Loading...
Analysis reveals weaknesses in defensive capability of listed companies under company law, suggesting regulatory reforms.
Zhe Zhang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: